Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Acadia Pharmaceuticals reported $-57776000 in Operating Profit for its fiscal quarter ending in September of 2023.

Operating Profit Change Date
Acadia Pharmaceuticals USD -57776000 60.81M Sep/2023
ALKERMES USD 43.85M 195.34M Sep/2023
Alnylam Pharmaceuticals USD 213.87M 443.7M Sep/2023
Biogen USD 158.8M 428.1M Sep/2023
BioMarin Pharmaceutical USD 25.66M 33.21M Sep/2023
Bristol-Myers Squibb USD 2.33B 191M Sep/2023
Cara Therapeutics USD -28898000 3.44M Sep/2023
Corcept Therapeutics USD 31.18M 1.59M Sep/2023
Cytokinetics USD -122265000 216K Sep/2023
Eisai JPY 5.4B 20.63B Sep/2023
Incyte USD 214.7M 20.92M Sep/2023
Intra Cellular Therapies USD -29713000 17.47M Sep/2023
J&J USD 5.22B 1.55B Sep/2023
Marinus Pharmaceuticals USD -31646000 207K Sep/2023
Moderna USD -2012000000 145M Sep/2023
Neurocrine Biosciences USD 141.2M 67.6M Sep/2023
Pfizer USD -2927000000 5.1B Sep/2023
PTC Therapeutics USD -118164000 91.38M Sep/2023
Sarepta Therapeutics USD -48342000 16.82M Sep/2023
Ultragenyx Pharmaceutical USD -145097000 2.86M Sep/2023
Vanda Pharmaceuticals USD -2867000 4.87M Jun/2023
Vertex Pharmaceuticals USD 1.04B 11.7M Sep/2023